中文产业新闻评分61Chinese source
阿斯利康CLDN18.2 ADC Sonesitatug Vedotin在华上市申请获CDE受理
又一款CLDN 18.2 ADC新药上市申请获CDE受理，由乐普生物与康诺亚联合开发
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
又一款CLDN 18.2 ADC新药上市申请获CDE受理，由乐普生物与康诺亚联合开发
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.